Source: BioPharma-Reporter

Synpromics: Lonza adopts Synpromics' inducible promoters, expands bio manufacturing platform

Lonza and Synpromics move on to the commercialization of a number of inducible promoters to expand the formerâs manufacturing offerings.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100

Read more